$41.63
-0.46-1.09%
Last update: Nov 2, 9:35 AM
Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Quote, News & History
TEVANYSE
FDA approves Teva's Weltruza, a once-monthly injectable for adults with schizophrenia, eliminating the need for daily oral medication.
You can purchase shares of Teva Pharmaceutical Indus (NYSE:TEVA) through any online brokerage.
Other companies in Teva Pharmaceutical Indus’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Teva Pharmaceutical Indus has a consensus price target of $40.81.
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $41.63 last updated November 2, 2026 at 9:35 AM EST.
There are no upcoming dividends for Teva Pharmaceutical Indus.
Teva Pharmaceutical Indus does not have any upcoming earnings scheduled.
There is no upcoming split for Teva Pharmaceutical Indus.
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has...
